Navigation Links
Codexis Names Vice President, Intellectual Property
Date:9/23/2008

REDWOOD CITY, Calif., Sept. 23 /PRNewswire/ -- Codexis, Inc., today announced the appointment of Lynn Marcus-Wyner, Ph.D., as Vice President, Intellectual Property. She will be responsible for managing the company's intellectual property strategy, activities, and patent portfolio and will report to Douglas Sheehy, Vice President, General Counsel and Secretary.

Dr. Marcus-Wyner joins Codexis from Danisco A/S, where as Senior Director, Intellectual Assets US, she managed the United States patent department of the Genencor division. Previously, she was in private intellectual property law practice representing clients, including Genencor International, Inc., and Novartis Corporation, and held a legal patent management position at Sandoz Agro Inc. Dr. Marcus-Wyner was also a Patent Attorney at Zeneca Inc. (formerly ICI Americas Inc). Dr. Marcus-Wyner has a J.D. from the University of the Pacific, McGeorge School of Law and a Ph.D. in plant physiology from the University of California, Davis. Prior to law school, Dr. Marcus-Wyner was an Assistant Professor in the Plant and Soil Science Department at the University of Massachusetts, Amherst.

"Building and protecting our intellectual property portfolio is a key success factor for Codexis," Mr. Sheehy said. "Dr. Marcus-Wyner has broad experience counseling life science and bioindustrial companies on intellectual property law matters, and brings a proven track record in managing this important function in our industry," Mr. Sheehy said. "We are very pleased to add her to the Codexis legal team."

Codexis is a leading developer of proprietary biocatalysts that the company believes have the potential to revolutionize chemistry-based manufacturing processes across a variety of industries. The company has used its technology platform to enable biocatalyst-based commercial-scale drug manufacturing processes and delivered biocatalysts and drug products to some of the world's leading pharmaceutical companies. Codexis has a funded research collaboration in the biofuels market, and the company is pursuing funded collaborations in several other bioindustrial markets, including carbon management, water treatment and chemicals.
CONTACT: Lyn Christenson, lyn.christenson@codexis.com,

650-421-8144, or Justin Jackson, jjackson@burnsmc.com,

Burns McClellan, 212-213-0006


'/>"/>
SOURCE Codexis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Codexis, Arch Announce Expanded Collaboration
2. Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering
3. Codexis Names David Anton VP Bioindustrials R&D
4. Codexis Launches Codex(TM) MicroCyp Platform to Produce Drug Metabolites and Novel Lead Compounds
5. Rothwell, Wolf Elected to Codexis Board
6. Codexis Opens Singapore Laboratory
7. Bruce Pasternack Elected to Codexis Board
8. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
9. Codexis Appoints Singapore Laboratories Managing Director
10. Genstruct Names Louis Latino VP of Sales
11. Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)...  Sequenom, Inc. (NASDAQ: SQNM ), a ... the development of innovative products and services, announced today ... States denied its petition to review decisions ... U.S. Patent No. 6,258,540 (",540 Patent") are not patent ... Supreme Court,s Mayo Collaborative Services v. Prometheus Laboratories decision.  ...
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in ... peritoneal or pleural mesothelioma. Their findings are the subject of a new article on ... biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients that ...
(Date:6/23/2016)... SPRING, Md. , June 23, 2016 A ... collected from the crime scene to track the criminal down. ... and the U.S. Food and Drug Administration (FDA) uses DNA ... Sound far-fetched? It,s not. The ... genome sequencing to support investigations of foodborne illnesses. Put as ...
Breaking Biology Technology:
(Date:5/12/2016)... 12, 2016 WearablesResearch.com , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
(Date:5/3/2016)... 2016  Neurotechnology, a provider of high-precision biometric ... Biometric Identification System (ABIS) , a complete system ... ABIS can process multiple complex biometric transactions with ... fingerprint, face or iris biometrics. It leverages the ... MegaMatcher Accelerator , which have been used ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
Breaking Biology News(10 mins):